{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:08:15Z","timestamp":1771934895877,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":4158,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1177\/1087057110384612","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T03:23:37Z","timestamp":1287026617000},"page":"1204-1210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Disease-Relevant High-Content Screening Assay to Identify Anti-Inflammatory Compounds for Use in Cystic Fibrosis"],"prefix":"10.1016","volume":"15","author":[{"given":"Angela M.","family":"Giddings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rangan","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1177\/1087057110384612_bib1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1542\/peds.2009-2791","article-title":"Cystic fibrosis and transition to adult medical care","volume":"125","author":"Tuchman","year":"2010","journal-title":"Pediatrics"},{"key":"10.1177\/1087057110384612_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1055\/s-0029-1238911","article-title":"Genetics of cystic fibrosis","volume":"30","author":"Lommatzsch","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1177\/1087057110384612_bib3","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.2174\/138161206777585148","article-title":"CFTR chloride channel drug discovery: inhibitors as antidiarrheals and activators for therapy of cystic fibrosis","volume":"12","author":"Verkman","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1177\/1087057110384612_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.mcg.0000155140.63510.cd","article-title":"Cystic fibrosis: an overview","volume":"39","author":"Turcios","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1177\/1087057110384612_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1191\/1479972305cd078ra","article-title":"Physiotherapy management of cystic fibrosis","volume":"2","author":"Dodd","year":"2005","journal-title":"Chron Respir Dis"},{"key":"10.1177\/1087057110384612_bib6","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1128\/IAI.73.11.7151-7160.2005","article-title":"Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5","volume":"73","author":"Zhang","year":"2005","journal-title":"Infect Immun"},{"key":"10.1177\/1087057110384612_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1465-9921-6-26","article-title":"Airway epithelial cell tolerance to Pseudomonas aeruginosa","volume":"6","author":"Wu","year":"2005","journal-title":"Respir Res"},{"key":"10.1177\/1087057110384612_bib8","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/BST0370863","article-title":"Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation","volume":"37","author":"Buchanan","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1177\/1087057110384612_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0091-6749(99)70116-8","article-title":"Altered respiratory epithelial cell cytokine production in cystic fibrosis","volume":"104","author":"Bonfield","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1177\/1087057110384612_bib10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1177\/1087057110384612_bib11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJM200003233421204","article-title":"Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis","volume":"342","author":"Lai","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1177\/1087057110384612_bib12","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199503303321303","article-title":"Effect of high-dose ibuprofen in patients with cystic fibrosis","volume":"332","author":"Konstan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1177\/1087057110384612_bib13","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaci.2006.01.052","article-title":"Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation","volume":"117","author":"Saadane","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1177\/1087057110384612_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF03256650","article-title":"The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy","volume":"2","author":"Wright","year":"2003","journal-title":"Am J Respir Med"},{"key":"10.1177\/1087057110384612_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1592\/phco.25.4.555.61025","article-title":"Antiinflammatory therapies for cystic fibrosis: past, present, and future","volume":"25","author":"Prescott","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"suppl 2","key":"10.1177\/1087057110384612_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jcf.2004.05.040","article-title":"Established cell lines used in cystic fibrosis research","volume":"3","author":"Gruenert","year":"2004","journal-title":"J Cyst Fibros"},{"key":"10.1177\/1087057110384612_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-9255-6-15","article-title":"Inhibition of NFkappaB by the natural product Withaferin A in cellular models of cystic fibrosis inflammation","volume":"6","author":"Maitra","year":"2009","journal-title":"J Inflamm (Lond)"},{"key":"10.1177\/1087057110384612_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10456-004-1026-3","article-title":"Withaferin A is a potent inhibitor of angiogenesis","volume":"7","author":"Mohan","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1177\/1087057110384612_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"10.1177\/1087057110384612_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1165\/rcmb.2003-0329OC","article-title":"Toll-like receptors in normal and cystic fibrosis airway epithelial cells","volume":"30","author":"Muir","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1177\/1087057110384612_bib21","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.4049\/jimmunol.174.3.1638","article-title":"TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells","volume":"174","author":"Greene","year":"2005","journal-title":"J Immunol"},{"key":"10.1177\/1087057110384612_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1164\/rccm.200207-765OC","article-title":"Cytokine secretion by cystic fibrosis airway epithelial cells","volume":"169","author":"Becker","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1177\/1087057110384612_bib23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00247-005-1445-3","article-title":"Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment","volume":"35","author":"Moskowitz","year":"2005","journal-title":"Pediatr Radiol"},{"key":"10.1177\/1087057110384612_bib24","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1378\/chest.117.5.1482","article-title":"The role of nuclear factor-kappa B in pulmonary diseases","volume":"117","author":"Christman","year":"2000","journal-title":"Chest"},{"issue":"2","key":"10.1177\/1087057110384612_bib25","first-page":"CD001915","article-title":"Inhaled corticosteroids for cystic fibrosis","author":"Dezateux","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1177\/1087057110384612_bib26","first-page":"900","article-title":"Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future","volume":"2","author":"Oermann","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1177\/1087057110384612_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-277X.2007.00824.x","article-title":"Appetite stimulants in cystic fibrosis: a systematic review","volume":"20","author":"Chinuck","year":"2007","journal-title":"J Hum Nutr Diet"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1087057110384612","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1087057110384612","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247255522208011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247255522208011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1087057110384612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T11:35:51Z","timestamp":1762860951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247255522208011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S247255522208011X"],"URL":"https:\/\/doi.org\/10.1177\/1087057110384612","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Disease-Relevant High-Content Screening Assay to Identify Anti-Inflammatory Compounds for Use in Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1177\/1087057110384612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Society for Laboratory Automation and Screening. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}